Home  / Global / Pharmaceuticals Register for Membership

New Report Available: EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

Published on 19 March 2013

Discover the World Of Judaica

by Bill Thompson


Boston, MA

Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. Vaccination has been shown to reduce influenza morbidity and mortality and high economic burden associated with influenza illness. GlobalData's epidemiologists expect seasonal influenza vaccination coverage rates for all countries but the UK and China to remain constant on average throughout the forecast period. Vaccine demand for all nine countries, on the other hand, is forecast to increase in the next decade. Overall, the US is projected to have the largest vaccine demand in the next decade at over 158 million, followed by Japan's 37.4 million, whereas Spain is expected to have the lowest demand at just over eight million. Annual growth in vaccine demand for the next 10 years is highest in India (2.10%) and the UK (1.38%) and lowest in Japan (0.42%) and Germany (0.26%). By 2022, the US will have the highest vaccination coverage rate (46.1%) and India and China the lowest (both at 1.7%). Vaccine demand is expected to increase across all nine markets, even in countries where vaccination coverage rates remain stable. This increase is mostly due to population growth, especially growth in the elderly age group.

View Full Report Details (http://www.fastmr.com/prod/529904_epicast_report_seasonal_influenza_vaccines.aspx?afid=201)


- The Seasonal Influenza Vaccines EpiCast Report provides an overview of risk factors for seasonal influenza and global trends for seasonal influenza vaccination coverage.
- Data provided for the US, France, Germany, Italy, Spain, the UK, Japan, India, and China.
- It includes a 10-year epidemiological forecast of seasonal influenza vaccination coverage segmented by age (0-4 years, 5-64 years, and =65 years) in these nine markets.

Reasons to buy

- This forecast is supported by at least 10 years of historical data sourced mostly from government reports and country-specific studies published by peer-reviewed journals.
- A major strength of the analysis is the consideration of a comprehensive list of factors such as policy, historical and current events, such as the H1N1 pandemic, cultural perception, economic situations, and population growth in forecasting trends.
- Forecast methodology is consistent across all nine markets, thereby allowing for a meaningful comparison of the nine markets.

Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget.  For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.


  • Bill Thompson
  • Fast Market Research, Inc.
  • PR Contact
  • Tel: +14134857001
Enter your email:
Enter Subject:
Enter your message:
Please enter this numbers in the fields:
  Click image to get a new code.
Enter code:

Posted 2013-03-19 09:10:00